catechin has been researched along with Aberrant Crypt Foci in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 3 (75.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chang, WL; Clapper, ML; Cooper, HS | 1 |
| Chen, H; Fang, MZ; Huang, SL; Jin, HY; Kong, DS; Li, M; Sun, Y; Wang, SM; Wang, XF; Wang, Y; Zhang, X | 1 |
| Buttar, NS; Della'Zanna, G; Foster, NR; Gostout, CJ; Kalaiger, AM; Kisiel, JB; Kraichely, RE; Larson, MV; Limburg, PJ; Meyers, JP; Patai, ÁV; Schroeder, KW; Sedlack, RE; Sinicrope, FA; Song, LMWK; Sontag, S; Umar, A; Viggiano, TR; Yang, CS | 1 |
| Cai, YK; Chen, J; Chen, WJ; Hao, Z; Lv, Y; Wang, HP; Wang, X; Ye, T; Zhao, JY | 1 |
1 review(s) available for catechin and Aberrant Crypt Foci
| Article | Year |
|---|---|
Dysplastic Aberrant Crypt Foci: Biomarkers of Early Colorectal Neoplasia and Response to Preventive Intervention.
Topics: Aberrant Crypt Foci; Adenoma; Adenomatous Polyposis Coli Protein; Animals; Antineoplastic Agents; Aspirin; Atorvastatin; Carcinogenesis; Catechin; Clinical Trials as Topic; Colon; Colonoscopy; Colorectal Neoplasms; Dietary Supplements; Disease Models, Animal; Humans; Intestinal Mucosa; Lycopene; Mice; Mutation; Treatment Outcome | 2020 |
1 trial(s) available for catechin and Aberrant Crypt Foci
| Article | Year |
|---|---|
Randomized Phase II Trial of Polyphenon E versus Placebo in Patients at High Risk of Recurrent Colonic Neoplasia.
Topics: Aberrant Crypt Foci; Aged; Catechin; Colon; Colonoscopy; Colorectal Neoplasms; Female; Follow-Up Studies; Humans; Intestinal Mucosa; Male; Middle Aged; Neoplasm Recurrence, Local; Placebos; Rectum; Treatment Outcome | 2021 |
2 other study(ies) available for catechin and Aberrant Crypt Foci
| Article | Year |
|---|---|
Epigallocatechin gallate inhibits dimethylhydrazine-induced colorectal cancer in rats.
Topics: Aberrant Crypt Foci; Animals; Anticarcinogenic Agents; Carcinogenesis; Catechin; Cell Proliferation; Colon; Colorectal Neoplasms; Dimethylhydrazines; Gene Expression Regulation, Neoplastic; Gene Regulatory Networks; Humans; Intestinal Mucosa; Male; Neoplasms, Experimental; Protein Interaction Maps; Rats; Rectum; Signal Transduction | 2020 |
Structural shift of gut microbiota during chemo-preventive effects of epigallocatechin gallate on colorectal carcinogenesis in mice.
Topics: Aberrant Crypt Foci; Animals; Anticarcinogenic Agents; Azoxymethane; Carcinogenesis; Carcinogens; Catechin; Colon; Colorectal Neoplasms; Dextran Sulfate; Disease Models, Animal; Female; Gastrointestinal Microbiome; Humans; Mice; Rectum; RNA, Ribosomal, 16S | 2017 |